Pub. Date : 2022 Feb 28
PMID : 35119858
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | NSP-037 (18), an irreversible inhibitor of the L858R/T790M double-mutant EGFR (EGFRDM) using alpha-chlorofluoroacetamide (CFA) as a novel warhead, has seven times the inhibition selectivity for EGFRDM over the wild type (EGFRWT), as compared to clinically approved osimertinib (7). | osimertinib | epidermal growth factor receptor | Homo sapiens |
2 | NSP-037 (18), an irreversible inhibitor of the L858R/T790M double-mutant EGFR (EGFRDM) using alpha-chlorofluoroacetamide (CFA) as a novel warhead, has seven times the inhibition selectivity for EGFRDM over the wild type (EGFRWT), as compared to clinically approved osimertinib (7). | osimertinib | epidermal growth factor receptor | Homo sapiens |